In February 2006, Epitek reached a minority equity investment agreement with Guidant Corporation (St Paul, MN) - (now Boston Scientific) who now has a seat at Epitek’s board.

Boston Scientific is one of the world’s leading medical device companies, with a particular expertise in minimally-invasive surgery. This agreement brings very positive validation to Epitek’s technology and will also allow for future potential collaboration.

In February 2007, Epitek raised $7.3 million to further continue the Anchorage development and testing, and design freeze.

“These funds will allow Epitek to complete the Anchorage Closure System™ design freeze, initiate the regulatory approval processes in the United States and in Europe and commence clinical studies in specific indications that will lead to favorable reimbursement patterns.” - Jean Paul Rasschaert, President, Chief Executive Officer, and Chairman of the Board.

The Anchorage Closure Device™ is an investigational product and is not for sale in the USA


For more information please e-mail: info[at]epitekinc.com